title: Tacrolimus (FK506) monotherapy provides potent and significant suppression of allogeneic foetal rat pancreatic allograft rejection.
authors.affiliation: Department of Anatomy and Histology, Faculty of Medicine, University of Stellenbosch, Tygerberg, South Africa.
authors.forename: D F
authors.initials: DF
authors.lastname: du Toit
authors.forename: C
authors.initials: C
authors.lastname: Muller
authors.forename: Y
authors.initials: Y
authors.lastname: Mouton
authors.forename: B
authors.initials: B
authors.lastname: Page
authors.forename: J
authors.initials: J
authors.lastname: Mattysen
authors.forename: R
authors.initials: R
authors.lastname: Lyners
authors.forename: C
authors.initials: C
authors.lastname: Woodroof
mesh_terms: D000818:Animals; D016332:Fetal Tissue Transplantation / Q000276:immunology* / Q000473:pathology; D005865:Gestational Age; D006084:Graft Rejection / Q000517:prevention & control*; D006085:Graft Survival; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008214:Lymphocytes / Q000276:immunology*; D016035:Pancreas Transplantation / Q000276:immunology* / Q000473:pathology; D051381:Rats; D011919:Rats, Inbred Strains; D017207:Rats, Sprague-Dawley; D016559:Tacrolimus / Q000627:therapeutic use*; D014184:Transplantation, Homologous; D014185:Transplantation, Isogeneic
chemical_list: D007166:Immunosuppressive Agents; D016559:Tacrolimus